Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMEXWWV)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Bromhexine hydrochloride; 611-75-6; Bromhexine HCl; Auxit; Bromohexine hydrochloride; Viscolyt; Bisolvon; Broncokin; Bromhexine chloride; Quentan; UNII-YC2ZOM3Z8V; Bromhexine (hydrochloride); Bromohexine monohydrochloride; 2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrochloride; YC2ZOM3Z8V; CHEBI:31303; NCGC00095005-01; AK163668; N-(2-Amino-3,5-dibromobenzyl)-N-methyl-cyclohexylammonium chloride; 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzylamine hydrochloride
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Bone
Osteosarcoma
Breast
Breast adenocarcinoma
Colon
Colorectal adenocarcinoma
Hematopoietic system
Normal
Kidney
Normal (Immortalized)
Liver
Hepatoblastoma
Hepatocellular carcinoma
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
